OKOmar Kreidieh

Omar Kreidieh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Omar Kreidieh has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reclassifying Single Lead Sinus Rhythm ECGs for Improved AF Recurrence Detection With Deep Learning

    by Yingshuo Liu, Chanho Lim, Ghassan Bidaoui, Christian Massad, Yunsung Chung, Hadi Younes, Mayana Bsoul, Yishi Jia, Abboud Hassan, Cong Zhao, et al.

    BACKGROUND: Atrial fibrillation (AF) remains a common outcome after catheter ablation, with recurrence observed in up to 50% of patients within 5 years. Despite extensive research, challenges remain in optimizing observation and prediction windows for AF recurrence assessment. Therefore, we developed and validated a novel deep learning model that reclassifies sinus rhythm based on past and future AF events using single-lead ECG strips from handheld devices. METHODS: Of the 558 participants, 308 with no documented recurrence during study follow-up contributed Benign Sinus strips, while 250 with documented recurrence contributed sinus rhythm strips recorded within ±3 days of an AF event, defined as Severe Sinus strips. Both clinical feature-based models and a deep learning model were used to classify these ECGs according to their proximity to AF recurrence events. Performance was evaluated using area under the receiver operating characteristic curve, accuracy, sensitivity, specificity, and F1-score. RESULTS: The strip-level pretrained deep learning model achieved an area under the receiver operating characteristic curve of 0.86, with sensitivity of 0.79, and specificity of 0.76. The complementary participant-level clinical feature-based Random Forest benchmark achieved an area under the receiver operating characteristic curve of 0.71, sensitivity of 0.58, and specificity of 0.69. Feature-based analyses identified associations involving heart-rate variability, mean R–R interval, female sex, left atrial volume, and mean P-wave duration. CONCLUSIONS: Our dynamic deep learning model reclassifies 30-second single-lead sinus rhythm ECGs based on AF events within ±3 days, transforming a brief ECG snapshot into a summarized indicator of short-term AF risk.

  • Open Access

    Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation

    by Michel Abou Khalil, Christian M. Massad, Eli Tsakiris, William Herbst, Maximilian Moersdorf, Mohammad Montaser Atasi, Yara Menassa, Alex El Darzi, Carlo El Khoury, Ghassan Bidaoui, et al.

    Background: Pulmonary vein isolation (PVI) is the standard ablation strategy for paroxysmal atrial fibrillation (PAF). Despite guideline recommendations favoring PVI alone in PAF, some operators routinely perform extra pulmonary vein ablation (PVI+) during initial procedures. Objective: To determine frequency of PVI+ strategy for treatment of PAF in the real world and examine its impact on arrhythmic recurrence and progression compared to PVI alone. Methods: Using the TriNetX research network, we identified adults with PAF who underwent catheter ablation between January 2020 and January 2024. Recurrence was defined as repeat ablation, cardioversion, or antiarrhythmic drug (AAD) use beyond a 3‐month blanking period. Progression to persistent AF and atypical atrial flutter were also assessed. Kaplan‐Meier analysis was performed with 3‐year follow‐up. Results: Before matching, 5134 of 18,891 patients (27.2%) underwent PVI+. In the propensity matched analysis ( n = 5020 per group), recurrence was significantly higher in the PVI+ group (HR 1.28, 95% CI 1.16–1.42; p < 0.001). Repeat ablation, cardioversion and AAD use were more common with PVI+ (HR 1.99, 95% CI 1.60–2.46; p < 0.0001, HR 1.37, 95% CI 1.13–1.66; p = 0.001, and HR 1.41, 95% CI 1.05–1.87; p = 0.020, respectively). Progression to persistent AF was higher with PVI+ (HR 1.37, 95% CI 1.23–1.53, p < 0.001), as was atypical atrial flutter (HR 2.63, 95% CI 1.97–3.50; p < 0.0001). Conclusion: Extra‐pulmonary vein ablation during first‐time PAF ablation remains common in real‐world practice but is associated with worse outcomes including repeat ablation, cardioversion, AAD use, atrial flutter, and progression to persistent AF.

  • Open Access

    Repeat catheter ablation vs. direct current cardioversion for recurrent atrial fibrillation after prior ablation: a propensity-matched analysis

    by Michel Abou Khalil, Mohammad Montaser Atasi, Yara Menassa, Maximilian Moersdorf, Christian M Massad, Alex El Darzi, Carlo El Khoury, Yishi Jia, Ghassan Bidaoui, Hadi Younes, et al.

  • Open Access

    Intraoperative PTH monitoring: does sampling site or assay generation matter?

    by Rola Kwayess, Sara Ajjour, Maya Rahme, Mariam Assaad, Marlene Chakhtoura, Omar Kreidieh, Jaber Abbas, Samar Jabbour-Khoury, Rose T Daher, Etienne Cavalier, et al.

    Context: Primary hyperparathyroidism (PHPT) is a common endocrine disorder for which minimally invasive parathyroidectomy (MIP) is the standard surgical approach. Intraoperative parathyroid hormone (IOPTH) monitoring is commonly performed using second-generation (2G) parathyroid hormone (PTH) assay. Objective: To compare the performance of IOPTH central sampling peripheral sampling, and third-generation (3G) vs 2G assays in patients with PHPT. Methods: This is a prospective cohort study conducted at American University of Beirut Medical Center, a tertiary hospital in Beirut, Lebanon. The study included 68 subjects with confirmed PHPT who achieved surgical cure, defined as normocalcemia at ≥6 months. IOPTH levels were measured from central and peripheral venous samples using 2G and 3G assays at various time points. Results: The median age was 57 years, and 80% were female. One-fourth had osteoporosis or reported kidney stones. Median preoperative calcium was 10.8 mg/dL with PTH 104 pg/mL, and 82% had single-gland disease. IOPTH levels were significantly higher with 2G assay and central sampling vs 3G assay and peripheral sampling. The proportion of patients meeting the Miami criterion did not differ between assays or sampling sites. Median percentage drop in IOPTH was greater with the 3G assay compared to 2G, across all time points, at both sampling sites. Conclusion: Although both assays similarly identified a ≥50% intraoperative decline, 3G assays demonstrated a steeper and more consistent drop, suggesting that higher assay-specific thresholds may improve decision-making. Central and peripheral sampling showed comparable predictive performance, although central sampling may allow earlier detection of PTH decline.


  • Open Access

    Pulsed Field Versus Radiofrequency Ablation in Concomitant Pulmonary Vein Isolation and LAA Occlusion: Impact on Peridevice Leak and Procedural Efficiency

    by Mohammad Montaser Atasi, Shea Hubbard, Charles Campbell, Charbel Noujaim, Christian M. Massad, Michel Abou Khalil, Yara Menassa, Alex El Darzi, Maximilian Moersdorf, Carlo El Khoury, et al.

    Background: Concomitant pulmonary vein isolation (PVI) and left atrial appendage occlusion (LAAO) is increasingly performed in patients with atrial fibrillation (AF) at elevated thromboembolic risk. Radiofrequency ablation (RFA) has been the conventional approach, but pulsed field ablation (PFA) may reduce tissue edema, procedural duration, and peridevice leak (PDL). Objective: To compare safety, efficacy, and PDL rates between PFA + LAAO and RFA + LAAO. Methods: In this single‐center, retrospective study, 175 consecutive patients undergoing LAAO with or without concomitant PVI between September 2021 and May 2025 were included: RFA + LAAO ( n = 61), PFA + LAAO ( n = 39), and LAAO‐only ( n = 75). Procedural data, device characteristics, and complications were collected. The primary endpoint was PDL at 45‐day follow‐up transesophageal echocardiography (TEE). Secondary endpoints included procedure duration, vascular and esophageal complications, device‐related thrombosis, and arrhythmia recurrence. Results: Baseline characteristics were generally balanced, although RFA + LAAO patients were younger. No large PDL (> 5 mm) was observed. At 45 days, small PDL (≤ 5 mm) was significantly higher in RFA + LAAO (23%) vs. PFA + LAAO (5.1%) and LAAO‐only (9.3%; p = 0.015). Mean procedure duration was shorter with PFA + LAAO (67.1 ± 10.4 min) compared with RFA + LAAO (99.6 ± 12.8 min; p < 0.001). Major complications and device‐related thrombosis were rare. Minor complications and AF recurrence were comparable across groups. Conclusions: Concomitant PFA + LAAO is associated with lower PDL incidence and shorter procedural times compared with RFA + LAAO, without compromising safety.


  • Open Access

    Gastrointestinal Bleeding Risk Associated With Pulse Pressure in Patients With Atrial Fibrillation: A Retrospective Cohort Study (Preprint)

    by Michel Abou Khalil, Carlo El Khoury, Maximilian Moersdorf, Christian Massad, Alex El Darzi, Yara Menassa, Mohammad Montaser Atasi, Ghassan Bidaoui, Hadi Younes, Ala Assaf, et al.

    Background: Patients with atrial fibrillation (AF) face significant bleeding risks, particularly those receiving oral anticoagulation; however, existing risk scores such as HAS-BLED and ORBIT demonstrate limited predictive accuracy. Pulse pressure (PP), calculated as the difference between systolic blood pressure (SBP) and diastolic blood pressure, is a noninvasive marker of arterial stiffness that has been associated with cardiovascular outcomes. However, PP has not been evaluated as a predictor of bleeding in this population. Objective: This study evaluated whether elevated PP independently predicts major bleeding events, overall and by subtype, in patients with AF after adjusting for established clinical risk factors. Methods: We conducted a retrospective cohort study using electronic health records from REACHnet, a PCORnet-affiliated clinical data network in Louisiana. A total of 4935 adults (mean age 63.7, SD 11.0 y; n=1606, 32.5% female) with AF between 2010 and 2019 were included via consecutive sampling of all eligible patients. PP was derived from outpatient blood pressure measurements closest to AF diagnosis and analyzed in tertiles (low: 62 mm Hg) and continuously per 10 mm Hg. The primary outcome was time to the first bleeding event, a composite of gastrointestinal bleeding, intracranial hemorrhage, and other clinically significant bleeding, identified using ICD-9 / ICD-10 codes. Kaplan-Meier survival curves with log-rank testing were used for univariable analysis. Multivariable Cox proportional hazards regression was adjusted for age, sex, race, comorbidities, medications, and the ORBIT score. A sensitivity analysis applied multivariable logistic regression additionally incorporating SBP. Statistical significance was set at P <.05. Results: Over a 5-year follow-up, 677 out of 4935 (13.7%) patients experienced a bleeding event (intracranial hemorrhage: n=60, 1.2%; gastrointestinal bleeding: n=195, 4.0%; and other bleeding: n=149, 3.0%). Gastrointestinal bleeding differed significantly across PP tertiles ( P= .007). Kaplan-Meier analysis confirmed lower gastrointestinal bleeding-free survival in the highest tertile (log-rank P= .004). No significant differences were observed for intracranial ( P= .08), other ( P =.58), or composite bleeding ( P =.22). In multivariable Cox regression, each 1 mm Hg increase in PP was independently associated with a 1.4% higher gastrointestinal bleeding risk (hazard ratio 1.014, 95% CI 1.001‐1.028; P= .04), approximately 15% per 10 mm Hg. This remained significant after adjusting for SBP and ORBIT score (odds ratio 1.013/mm Hg, 95% CI 1.001‐1.025; P =.03), while SBP was not independently significant ( P =.13). Conclusions: PP independently predicts gastrointestinal bleeding risk in patients with AF beyond established clinical risk factors and validated bleeding risk scores. Unlike prior investigations that examined SBP or diastolic blood pressure components in isolation, this is the first study to identify PP as a predictor of gastrointestinal bleeding in this population. As a readily available, low-cost hemodynamic parameter derived from routine clinical measurements, PP could enhance existing risk stratification tools and inform more personalized bleeding risk management strategies in patients with AF.

  • Machine Learning‐Driven Identification of Distinct Persistent Atrial Fibrillation Phenotypes: A Cluster Analysis of DECAAF II

    by Charbel Noujaim, Han Feng, Ghassan Bidaoui, Chao Huang, Hadi Younes, Ala Assaf, Mario Mekhael, Nour Chouman, Chanho Lim, Eoin Donnellan, et al.

    Introduction: Catheter ablation of persistent atrial fibrillation yields sub‐optimal success rates partly due to the considerable heterogeneity within the patient population. Identifying distinct patient phenotypes based on post‐ablation prognosis could improve patient selection for additional therapies and optimize treatment strategies.Methods: We studied all patients who underwent catheter ablation of persistent atrial fibrillation in the DECAAF II trial. Out of 44 participating centers, 25% were randomly chosen as a validation set. A Gradient Boosting Method determined essential features for arrhythmia recurrence prediction and the number of clusters was determined according to the average silhouette width. K‐medoids cluster analysis identified subgroups based on these features, and Kaplan–Meier curves were further compared among different clusters.Results: Among 815 patients, 570 served as a training set and 245 as a validation set. Using the training set, the GBM model achieved an AUC of 0.874. K‐medoids cluster analysis used LA volume, BMI, baseline fibrosis, and age, resulting in two clusters. Cluster 1 patients were older, had higher baseline fibrosis, higher BMI, and greater LA volume compared to Cluster 2. Atrial arrhythmia recurrence rates were significantly higher in Cluster 1 (51.7% vs. 35.0%, p = 0.0002), and survival analysis showed a significant difference in primary recurrence outcomes (HR = 1.71, p < 0.0001). The validation set confirmed these findings.Conclusion: Utilizing machine learning, we identified a high‐risk cluster for procedural failure in catheter ablation of persistent atrial fibrillation within the DECAAF II trial population. The primary differentiating factors of this high‐risk cluster include older age, high left atrial fibrosis, elevated BMI, and increased left atrial volume.


  • Open Access

    Lesion monitoring parameters as predictors of atrial arrhythmia recurrence after catheter ablation in persistent AF: A DECAAF II sub‐analysis

    by Mario Mekhael, Han Feng, Hadi Younes, Nour Chouman, Ala Assaf, Chanho Lim, Chao Huang, Eoin Donnellan, Swati Rao, Nassir Marrouche, et al.

    Background: The formation of transmural lesions is necessary for the ablation of persistent atrial fibrillation (prAF). Ablation index (AI) and generator impedance drop (ID) predict lesion size but their correlation with long‐term outcomes in prAF is not known. Furthermore, we proposed a new parameter, efficacy ratio (ER) calculated as ID/AI, to gain indirect insight into the role of factors affecting ID but not considered by AI.Methods: We included ablations performed during the DECAAF II trial if they had uploaded lesion‐by‐lesion summary data and were performed with radiofrequency catheters on the CARTO system. Average patient‐level parameters were calculated from all generated Vizitags.Results: A total of 427 ablations met inclusion criteria and 166 utilized AI. Analyzed as continuous variables, ID and ER predicted long‐term arrhythmia‐free survival but not AI. The ideal cut‐off for ID was ID ≥ 10.4 ohms and had a C‐index of 0.55. It predicted reduced risk of arrhythmia: hazard ratio 0.56 [0.36–0.88], p = .013 (arrhythmia‐free survival of 67% vs. 52%). Similarly, an ER of 1.7 ohms/100AI had a C‐index of 0.58 and predicted reduced arrhythmia recurrence: HR 0.39 [0.22–0.69], p = .001. ER < 1.7 ohms/100AI was related to just 32% arrhythmia‐free survival. ER improved prognostication as compared to ID alone and identified a subset of low ID patients with even worse outcomes.Conclusion: Average ID was predictive of improved outcomes following ablation of prAF. The ratio of ID/AI (ER) was postulated as a measure to summarize the overall impact of factors not considered in the AI formula and provided improved prognostication.


  • Open Access

    Body mass index as a determinant of scar formation post‐AF ablation: Insights from DECAAF II

    by Ghassan Bidaoui, Eli Tsakiris, Hadi Younes, Han Feng, Ala Assaf, Nour Chouman, Mayana Bsoul, Francisco Tirado Polo, Yishi Jia, Yingshou Liu, et al.

    Introduction: Obesity is implicated in adverse atrial remodeling and worse outcomes in patients with atrial fibrillation. The objective of this study is to assess the effect of body mass index (BMI) on ablation‐induced scar formation on late gadolinium enhancement cardiac magnetic resonance imaging (LGE‐CMR).Methods: We conducted an analysis of DECAAF II participants who underwent LGE‐CMR scans to measure scar formation 3 months after catheter ablation. Ablation parameters and lesion delivery were not dependent on BMI. The effect of BMI on ablation success was explored.Results: Our analyses included 811 patients. Comorbidities were more prevalent in obese patients. Baseline left atrial volume was higher in obese individuals, 118, 126, 135, 140, and 143 mm3 for normal weight, overweight, obese grade 1, 2, and 3, respectively (p < .001). BMI was associated with scar formation (R = −0.135, p < .001), with patients with Class 3 obesity having the lowest percentage of ablation‐induced scar, 11.1%, 10.3%, 9.5%, 8.8%, 6.8% by ascending BMI group. There was an inverse correlation between BMI and the amount of fibrosis covered by ablation scar, 24%, 23%, 21%, and 18% by ascending BMI group (p = .001). For the fibrosis‐guided ablation group, BMI was associated with residual fibrosis (R = 0.056, p = .005).Conclusion: Obese patients have lower ablation scar formation, covered fibrosis, and more residual fibrosis postablation compared to nonobese patients, regardless of ablation parameters including impedance drop.


  • Open Access

    Consistency of ablations with trainee and increasing independence during fellowship training—Analysis of ablation data by CARTONET

    by John Whitaker, Tina D. Hunter, Jane Carsey, William H. Thatcher, Don Yungher, Stanislav Goldberg, Christina Kaneko, Mati Amit, Omar Kreidieh, Clinton Thurber, et al.

    Introduction: Training in clinical cardiac electrophysiology (CCEP) involves the development of catheter handling skills to safely deliver effective treatment. Objective data from analysis of ablation data for evaluating trainee of CCEP procedures has not previously been possible. Using the artificial intelligence cloud‐based system (CARTONET), we assessed the impact of trainee progress through ablation procedural quality.Methods: Lesion‐ and procedure‐level data from all de novo atrial fibrillation (AF) and cavotricuspid isthmus (CTI) ablations involving first‐year (Y1) or second‐year (Y2) fellows across a full year of fellowship was curated within Cartonet. Lesions were automatically assigned to anatomic locations.Results: Lesion characteristics, including contact force, catheter stability, impedance drop, ablation index value, and interlesion time/distance were similar over each training year. Anatomic location and supervising operator significantly affected catheter stability. The proportion of lesion sets delivered independently and of lesions delivered by the trainee increased steadily from the first quartile of Y1 to the last quartile of Y2. Trainee perception of difficult regions did not correspond to objective measures.Conclusion: Objective ablation data from Cartonet showed that the progression of trainees through CCEP training does not impact lesion‐level measures of treatment efficacy (i.e., catheter stability, impedance drop). Data demonstrates increasing independence over a training fellowship. Analyses like these could be useful to inform individualized training programs and to track trainee's progress. It may also be a useful quality assurance tool for ensuring ongoing consistency of treatment delivered within training institutions.